➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Express Scripts
Merck
Medtronic
McKinsey

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

ARISTOCORT Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Aristocort, and what generic alternatives are available?

Aristocort is a drug marketed by Astellas and Fosun Pharma and is included in fourteen NDAs.

The generic ingredient in ARISTOCORT is triamcinolone. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone profile page.

Drug patent expirations by year for ARISTOCORT
Recent Clinical Trials for ARISTOCORT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Center for Research Resources (NCRR)N/A
Mayo ClinicN/A

See all ARISTOCORT clinical trials

US Patents and Regulatory Information for ARISTOCORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas ARISTOCORT triamcinolone acetonide CREAM;TOPICAL 083017-003 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Astellas ARISTOCORT A triamcinolone acetonide CREAM;TOPICAL 083015-003 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Astellas ARISTOCORT triamcinolone acetonide OINTMENT;TOPICAL 080745-002 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Fosun Pharma ARISTOCORT triamcinolone diacetate INJECTABLE;INJECTION 011685-003 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Astellas ARISTOCORT triamcinolone TABLET;ORAL 011161-011 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Moodys
McKesson
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.